|
|
The FDA recognizes 118 routes of administration.
All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.
By definition, when a medication is administered intravenously, its bioavailability is 100%.
Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.
Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.